G01N 2333/715
For cytokines
Official title: for cytokines; for lymphokines; for interferons
G01N2333/715 (For cytokines) appears on 386 US grants and 772 published applications in this corpus.
Search patents in G01N- Granted patents
- 386
- Published applications
- 772
- Assignees
- 422
- Inventors
- 1,473
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1991 | 1 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 1 | 0 |
| 1995 | 1 | 0 |
| 1996 | 1 | 0 |
| 1997 | 0 | 0 |
| 1998 | 1 | 0 |
| 1999 | 5 | 0 |
| 2000 | 5 | 0 |
| 2001 | 3 | 0 |
| 2002 | 3 | 8 |
| 2003 | 4 | 12 |
| 2004 | 3 | 10 |
| 2005 | 4 | 18 |
| 2006 | 4 | 14 |
| 2007 | 5 | 18 |
| 2008 | 7 | 23 |
| 2009 | 9 | 20 |
| 2010 | 13 | 23 |
| 2011 | 10 | 26 |
| 2012 | 13 | 29 |
| 2013 | 12 | 31 |
| 2014 | 14 | 29 |
| 2015 | 12 | 54 |
| 2016 | 17 | 35 |
| 2017 | 24 | 32 |
| 2018 | 31 | 61 |
| 2019 | 32 | 40 |
| 2020 | 34 | 47 |
| 2021 | 26 | 43 |
| 2022 | 22 | 40 |
| 2023 | 17 | 43 |
| 2024 | 12 | 36 |
| 2025 | 31 | 51 |
| 2026 | 9 | 29 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Drug-specific pharmacokinetic assay for IL-15 superagonist6 Oct 2026US 12,754,189 B2NantCell, Inc.
- Method of treating ichthyosis in a subject by administering an anti-interleukin 36 receptor (IL-36R) binding agent25 Aug 2026US 12,715,924 B2AnaptysBio, Inc.
- Composition for cancer diagnosis18 Aug 2026US 12,710,425 B2Acurasysbio Co., Ltd.
- Cytokine-based therapies and methods30 Jun 2026US 12,668,627 B2Reverb Therapeutics, Inc.
- Method for diagnosing human T-cell leukemia virus type 1 (HTLV-1)-related disease16 Jun 2026US 12,656,345 B2NEC Corporation
- Multi-Analyte Rapid Diagnostic Test for Sepsis Using Novel Biomarkers and Quantum Dot Technology1 Oct 2026US 2026/0298921 A1Trimar Domestic Inc.
- Novel cytokine-based therapies and methods17 Sep 2026US 2026/0274943 A1Reverb Therapeutics, Inc.
- Anti-ccr8 antibodies and uses thereof17 Sep 2026US 2026/0274972 A1Gilead Sciences, Inc.
- Methods of treating disorders using csf1r inhibitors20 Aug 2026US 2026/0240849 A1Deciphera Pharmaceuticals, LLC
- Photonic crystal biochip and protein detection method thereof20 Aug 2026US 2026/0243759 A1Beijing Institute of Heart Lung and Blood Vessel Diseases
Most cited
By later US patents
- Prostaglandin E2 dual variable domain immunoglobulins and uses thereof85US 8,822,645 B2AbbVie Inc. · 2014
- Methods of treating disorders using CSF1R inhibitors50US 11,103,507 B2Deciphera Pharmaceuticals, LLC · 2021
- IL1RL-1 as a cardiovascular disease marker and therapeutic target48US 7,670,769 B2The Brigham and Women S Hospital, Inc. · 2010
- Methods for diagnosis of cardiovascular disease47US 7,432,060 B2The Brigham and Women S Hospital, Inc. · 2008
- Predicting risk of major adverse cardiac events47US 8,090,562 B2Critical Care Diagnostics, Inc. · 2012